Stockholm-based Biolin Scientific Holding signs licensing agreement with Munich spin-out Nanion.
Nanion Technologies, a life sciences spin-out of Munich University, has signed a licensing agreement with Biolin Scientific Holding, a Sweden-based instrumentation company.
The deal, which was for an undisclosed fee, will allow Biolin access to Nanion’s patents. Founded in 2002, Nanion has been commercialising cell analysis technologies which provide high quality data through the use of multiple sets of ion channel screening.
Johan von Heijne, president and CEO of Biolin Scientific, said: “This deal affirms our commitment to invest in high-throughput screening using automated patch clamping, and our intent to vigorously protect our broad range of innovations and intellectual property rights. We are committed to our full range of brands including Sophion, Q-Sense, Attension and KSV NIMA branded products”.
Niels Fertig, CEO of Nanion Technologies, added: “The license agreement is fully in-line with our long-term strategy to safeguard our ability to continue to develop new and exciting products in the field of automated patch clamping”.
